Skip to main content
. 2025 Dec 6;26(24):11809. doi: 10.3390/ijms262411809
IHC Immunohistochemistry
ISH In situ hybridization
pCR Pathological complete response
NACT Neoadjuvant chemotherapy
cHER2+ HER2-positive based on pathology report
Her2MtGx HER2 MetaGene assay
p^ Estimated probability
SE Standard error
PPV Positive predictive value
NPV Negative predictive value